AIRLINK 73.53 Decreased By ▼ -2.17 (-2.87%)
BOP 4.67 Decreased By ▼ -0.05 (-1.06%)
CNERGY 4.01 Decreased By ▼ -0.09 (-2.2%)
DFML 36.09 Decreased By ▼ -3.33 (-8.45%)
DGKC 86.55 Decreased By ▼ -2.05 (-2.31%)
FCCL 21.98 Decreased By ▼ -0.62 (-2.74%)
FFBL 30.01 Decreased By ▼ -0.39 (-1.28%)
FFL 9.18 Decreased By ▼ -0.04 (-0.43%)
GGL 9.86 Decreased By ▼ -0.16 (-1.6%)
HASCOL 6.25 Increased By ▲ 0.20 (3.31%)
HBL 105.01 Decreased By ▼ -0.24 (-0.23%)
HUBC 137.45 Decreased By ▼ -0.79 (-0.57%)
HUMNL 10.75 No Change ▼ 0.00 (0%)
KEL 4.49 Decreased By ▼ -0.14 (-3.02%)
KOSM 3.99 Decreased By ▼ -0.25 (-5.9%)
MLCF 36.70 Decreased By ▼ -1.26 (-3.32%)
OGDC 119.40 Decreased By ▼ -2.00 (-1.65%)
PAEL 23.97 Decreased By ▼ -0.43 (-1.76%)
PIBTL 6.05 Decreased By ▼ -0.13 (-2.1%)
PPL 112.50 Increased By ▲ 0.15 (0.13%)
PRL 22.81 Decreased By ▼ -0.62 (-2.65%)
PTC 11.90 Decreased By ▼ -0.66 (-5.25%)
SEARL 58.40 Decreased By ▼ -0.30 (-0.51%)
SNGP 61.11 Decreased By ▼ -0.44 (-0.71%)
SSGC 9.65 Decreased By ▼ -0.19 (-1.93%)
TELE 7.55 Decreased By ▼ -0.27 (-3.45%)
TPLP 9.54 Decreased By ▼ -0.26 (-2.65%)
TRG 63.10 Decreased By ▼ -1.09 (-1.7%)
UNITY 26.80 No Change ▼ 0.00 (0%)
WTL 1.29 Decreased By ▼ -0.06 (-4.44%)
BR100 7,566 Decreased By -60.2 (-0.79%)
BR30 24,087 Decreased By -272.5 (-1.12%)
KSE100 72,589 Decreased By -663.1 (-0.91%)
KSE30 23,137 Decreased By -263.6 (-1.13%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published February 16, 2019 Updated February 18, 2019

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed.